Liao Yi-Jun, Mi Si-Yuan, Kang Da, Tang Xin, Chen Gong, Pan Zhi-Zhong, Zhang Rong-Xin
Department of Colorectal Surgery, Sun Yat-Sen University Cancer Centre, Guangzhou, 510060, Guangdong, People's Republic of China.
State Key Laboratory of Oncology in South China, Guangzhou, 510060, Guangdong, People's Republic of China.
Updates Surg. 2025 Jun 4. doi: 10.1007/s13304-025-02263-5.
Laparoscopic right hemicolectomy (Lap-RHC) presents technical challenges due to the complex vascular anatomy of the mesentery, which increases the risk of intraoperative bleeding and complicates surgical navigation. Accurate identification of the superior mesenteric vein (SMV) is crucial for maintaining surgical safety and achieving optimal oncological outcomes. To address these challenges, this study proposes the terminal ileal vein (TIV) approach, a novel technique designed to facilitate precise SMV identification and enable en bloc resection of the ileal mesentery while preserving mesenteric integrity. This retrospective cohort study evaluated a novel TIV approach compared to the traditional ileocolic vascular pedicle (IVP) approach for SMV identification and en bloc mesentery resection in patients with right-sided colon cancer. A total of 196 patients underwent Lap-RHC between 2022 and 2023, with 67 patients matched by propensity score included in both groups. The TIV approach involves initiating dissection at the TIV to accurately locate the SMV and facilitate en bloc resection of the ileal mesentery. In the balanced cohort, statistically significant differences were observed between groups regarding operation times (186 [120-299] vs. 210 [146-375] minutes, p = 0.001) and intraoperative blood loss (50 [20-400] vs. 70 [20-600] mL, p = 0.033). Differences were also found for time to urinary catheter removal (1 [1-3] vs. 2 [1-5] days, p = 0.012) and postoperative hospital stays (6 [5-12] vs. 7 [5-15] days, p = 0.006). The calculated importance proportion of the TIV approach related to these perioperative variables was between 15 and 25%. In this retrospective cohort, the TIV approach demonstrated reproducible entry into the mesenteric dissection plane and was accompanied by perioperative outcome differences that may reflect technical simplification. Further prospective investigation is needed to determine its clinical utility.
由于肠系膜复杂的血管解剖结构,腹腔镜右半结肠切除术(Lap-RHC)面临技术挑战,这增加了术中出血风险并使手术导航复杂化。准确识别肠系膜上静脉(SMV)对于维持手术安全和实现最佳肿瘤学结果至关重要。为应对这些挑战,本研究提出了终末回肠静脉(TIV)入路,这是一种旨在促进精确识别SMV并在保留肠系膜完整性的同时实现回肠系膜整块切除的新技术。这项回顾性队列研究评估了一种新型TIV入路与传统回结肠血管蒂(IVP)入路在右侧结肠癌患者中识别SMV和整块肠系膜切除方面的效果。2022年至2023年期间共有196例患者接受了Lap-RHC,两组各纳入67例倾向评分匹配的患者。TIV入路是从终末回肠静脉开始进行解剖,以准确定位SMV并促进回肠系膜的整块切除。在平衡队列中,两组在手术时间(186[120 - 299]分钟 vs. 210[146 - 375]分钟,p = 0.001)和术中失血量(50[20 - 400]毫升 vs. 70[20 - 600]毫升,p = 0.033)方面存在统计学显著差异。在拔除尿管时间(1[1 - 3]天 vs. 2[1 - 5]天,p = 0.012)和术后住院时间(6[5 - 12]天 vs. 7[5 - 15]天,p = 0.006)方面也发现了差异。TIV入路与这些围手术期变量相关的计算重要比例在15%至25%之间。在这个回顾性队列中,TIV入路显示出可重复进入肠系膜解剖平面,并伴随着可能反映技术简化的围手术期结果差异。需要进一步的前瞻性研究来确定其临床实用性。